Clinical trial
Predictive Value of Cumulative Intra-Abdominal Pressure Burden for Acute Kidney Injury in Critically Ill Patients Following Emergency Abdominal Surgery: A Prospective Observational Cohort Study
NCT07891026 is registered in ClinicalTrials.gov with Ugur Duman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Value of Cumulative Intra-Abdominal Pressure Burden for Acute Kidney Injury in Critically Ill Patients Following Emergency Abdominal Surgery: A Prospective Observational Cohort Study
- Lead sponsor
- Ugur Duman
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 1, 2026
- Completion date
- November 30, 2027
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
Arms
As registered; 1 arm.
-
Emergency Abdominal Surgery ICU Cohort
Adult patients admitted to the intensive care unit following emergency abdominal surgery, including open and laparoscopic procedures, will be prospectively enrolled in a single observational cohort. During the first 48 postoperative hours, intra-abdominal pressure will be measured serially using the intravesical pressure measurement technique. Mean arterial pressure will be recorded simultaneously, and abdominal perfusion pressure will be calculated as MAP minus IAP. Cumulative pressure burden parameters will be evaluated for their association with acute kidney injury occurring within the first seven postoperative days, according to KDIGO criteria. All patients will receive standard clinical care without any study-directed therapeutic intervention.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Incidence of Acute Kidney Injury Within Seven Postoperative Days
The proportion of participants who develop acute kidney injury (AKI) within seven days following emergency abdominal surgery. AKI will be defined and staged according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria using changes in serum creatinine concentrations and urine output.
Lead sponsor's other trials
Ugur Duman, most recent start first.
Similar trials
Same condition (Intra-Abdominal Hypertension) and phase, most recent start first.
+32 more trials See the condition page